A reduced retesting program for raw materials was in place without the raw material vendor certification. The standard operating procedures or records for shipping and receiving raw materials were inadequate.
Inspection Record
Lawson Health Research Institute — Health Canada Inspection Findings
View the regulator's official source The source document is always the basis for judgement.
Findings
The premises were not designed, constructed, operated, and/or maintained to prevent contamination. The premises were not designed, constructed, operated, and/or maintained to allow clean and orderly conditions.
The annual product quality review procedure was inadequate.
The usage logs for the equipment used for significant processing and/or testing operations were inadequate.
The implementation of a self-inspection program was inadequate.
The master formulas to control the manufacturing process were inadequate.
The controls were inadequate for creating, modifying, reviewing, storing, and/or retrieving records.
Evaluation of production processes, equipment, and/or materials was inadequate.
The guidelines and/or procedures were inadequate in ensuring storage and/or transportation conditions would maintain the quality and safe distribution of the drug.
About this record
Extracted automatically from the document of the Health Canada inspection on 2025-12-15. The source is available at the link above.
This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.
Translation and classification are automated and may differ in nuance from the source.
